GPT and metabolic dysfunction-associated steatohepatitis: Among the 38 patients who were not randomized, the most common reasons were an ALT or AST not greater than 40 IU/L (14 patients), liver biopsy not demonstrating features consistent with NASH without cirrhosis as determined by the site pathologist (7 patients), and withdrawal of consent (7 patients).